世界と中国の医薬品再利用市場の規模、現状、見通し 2021-2027年Global and China Drug Repurposing Market Size, Status and Forecast 2021-2027 市場分析と洞察。医薬品再利用の世界市場 Drug Repurposingの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されています。 本レポートは、業界... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場分析と洞察。医薬品再利用の世界市場Drug Repurposingの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されています。 本レポートは、業界標準の正確な分析と高いデータ整合性により、世界のDrug Repurposing市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界のDrug Repurposing市場の全体的なサイズも含まれています。 全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の医薬品再利用市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のDrug Repurposing市場を詳細に調査するために、独自の業界最高の調査・分析手法を採用しました。 世界の医薬品再利用の範囲と市場規模 Drug Repurposing市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のDrug Repurposing市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント 静脈内投与 経口投与 用途別セグメント 心血管障害 中枢神経系疾患 オンコロジー その他 地域別 北アメリカ アメリカ カナダ ヨーロッパ ドイツ フランス U.K. イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 ファイザー ロシュ ノバルティス社 アボット・ヘルスケア ジョンソン・エンド・ジョンソン サンドラッグ マイラン社 テバ・ファーマシューティカルズ 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Intravenous 1.2.3 Oral 1.3 Market by Application 1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular Disorders 1.3.3 Central Nervous Disorders 1.3.4 Oncology 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drug Repurposing Market Perspective (2016-2027) 2.2 Drug Repurposing Growth Trends by Regions 2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021) 2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027) 2.3 Drug Repurposing Industry Dynamic 2.3.1 Drug Repurposing Market Trends 2.3.2 Drug Repurposing Market Drivers 2.3.3 Drug Repurposing Market Challenges 2.3.4 Drug Repurposing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Repurposing Players by Revenue 3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021) 3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021) 3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Drug Repurposing Revenue 3.4 Global Drug Repurposing Market Concentration Ratio 3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020 3.5 Drug Repurposing Key Players Head office and Area Served 3.6 Key Players Drug Repurposing Product Solution and Service 3.7 Date of Enter into Drug Repurposing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Repurposing Breakdown Data by Type 4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021) 4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027) 5 Drug Repurposing Breakdown Data by Application 5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021) 5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Drug Repurposing Market Size (2016-2027) 6.2 North America Drug Repurposing Market Size by Type 6.2.1 North America Drug Repurposing Market Size by Type (2016-2021) 6.2.2 North America Drug Repurposing Market Size by Type (2022-2027) 6.2.3 North America Drug Repurposing Market Size by Type (2016-2027) 6.3 North America Drug Repurposing Market Size by Application 6.3.1 North America Drug Repurposing Market Size by Application (2016-2021) 6.3.2 North America Drug Repurposing Market Size by Application (2022-2027) 6.3.3 North America Drug Repurposing Market Size by Application (2016-2027) 6.4 North America Drug Repurposing Market Size by Country 6.4.1 North America Drug Repurposing Market Size by Country (2016-2021) 6.4.2 North America Drug Repurposing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Drug Repurposing Market Size (2016-2027) 7.2 Europe Drug Repurposing Market Size by Type 7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021) 7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027) 7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027) 7.3 Europe Drug Repurposing Market Size by Application 7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021) 7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027) 7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027) 7.4 Europe Drug Repurposing Market Size by Country 7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021) 7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027) 8.2 Asia-Pacific Drug Repurposing Market Size by Type 8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027) 8.3 Asia-Pacific Drug Repurposing Market Size by Application 8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027) 8.4 Asia-Pacific Drug Repurposing Market Size by Region 8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Drug Repurposing Market Size (2016-2027) 9.2 Latin America Drug Repurposing Market Size by Type 9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021) 9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027) 9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027) 9.3 Latin America Drug Repurposing Market Size by Application 9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021) 9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027) 9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027) 9.4 Latin America Drug Repurposing Market Size by Country 9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021) 9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027) 10.2 Middle East & Africa Drug Repurposing Market Size by Type 10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027) 10.3 Middle East & Africa Drug Repurposing Market Size by Application 10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027) 10.4 Middle East & Africa Drug Repurposing Market Size by Country 10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Drug Repurposing Introduction 11.1.4 Pfizer Revenue in Drug Repurposing Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Drug Repurposing Introduction 11.2.4 Roche Revenue in Drug Repurposing Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Novartis AG Business Overview 11.3.3 Novartis AG Drug Repurposing Introduction 11.3.4 Novartis AG Revenue in Drug Repurposing Business (2016-2021) 11.3.5 Novartis AG Recent Development 11.4 Abbott Healthcare 11.4.1 Abbott Healthcare Company Details 11.4.2 Abbott Healthcare Business Overview 11.4.3 Abbott Healthcare Drug Repurposing Introduction 11.4.4 Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021) 11.4.5 Abbott Healthcare Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Drug Repurposing Introduction 11.5.4 Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Sandoz 11.6.1 Sandoz Company Details 11.6.2 Sandoz Business Overview 11.6.3 Sandoz Drug Repurposing Introduction 11.6.4 Sandoz Revenue in Drug Repurposing Business (2016-2021) 11.6.5 Sandoz Recent Development 11.7 Mylan Inc. 11.7.1 Mylan Inc. Company Details 11.7.2 Mylan Inc. Business Overview 11.7.3 Mylan Inc. Drug Repurposing Introduction 11.7.4 Mylan Inc. Revenue in Drug Repurposing Business (2016-2021) 11.7.5 Mylan Inc. Recent Development 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Details 11.8.2 Teva Pharmaceuticals Business Overview 11.8.3 Teva Pharmaceuticals Drug Repurposing Introduction 11.8.4 Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021) 11.8.5 Teva Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryMarket Analysis and Insights: Global Drug Repurposing Market Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Intravenous 1.2.3 Oral 1.3 Market by Application 1.3.1 Global Drug Repurposing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular Disorders 1.3.3 Central Nervous Disorders 1.3.4 Oncology 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Drug Repurposing Market Perspective (2016-2027) 2.2 Drug Repurposing Growth Trends by Regions 2.2.1 Drug Repurposing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Drug Repurposing Historic Market Share by Regions (2016-2021) 2.2.3 Drug Repurposing Forecasted Market Size by Regions (2022-2027) 2.3 Drug Repurposing Industry Dynamic 2.3.1 Drug Repurposing Market Trends 2.3.2 Drug Repurposing Market Drivers 2.3.3 Drug Repurposing Market Challenges 2.3.4 Drug Repurposing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Repurposing Players by Revenue 3.1.1 Global Top Drug Repurposing Players by Revenue (2016-2021) 3.1.2 Global Drug Repurposing Revenue Market Share by Players (2016-2021) 3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Drug Repurposing Revenue 3.4 Global Drug Repurposing Market Concentration Ratio 3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2020 3.5 Drug Repurposing Key Players Head office and Area Served 3.6 Key Players Drug Repurposing Product Solution and Service 3.7 Date of Enter into Drug Repurposing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Repurposing Breakdown Data by Type 4.1 Global Drug Repurposing Historic Market Size by Type (2016-2021) 4.2 Global Drug Repurposing Forecasted Market Size by Type (2022-2027) 5 Drug Repurposing Breakdown Data by Application 5.1 Global Drug Repurposing Historic Market Size by Application (2016-2021) 5.2 Global Drug Repurposing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Drug Repurposing Market Size (2016-2027) 6.2 North America Drug Repurposing Market Size by Type 6.2.1 North America Drug Repurposing Market Size by Type (2016-2021) 6.2.2 North America Drug Repurposing Market Size by Type (2022-2027) 6.2.3 North America Drug Repurposing Market Size by Type (2016-2027) 6.3 North America Drug Repurposing Market Size by Application 6.3.1 North America Drug Repurposing Market Size by Application (2016-2021) 6.3.2 North America Drug Repurposing Market Size by Application (2022-2027) 6.3.3 North America Drug Repurposing Market Size by Application (2016-2027) 6.4 North America Drug Repurposing Market Size by Country 6.4.1 North America Drug Repurposing Market Size by Country (2016-2021) 6.4.2 North America Drug Repurposing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Drug Repurposing Market Size (2016-2027) 7.2 Europe Drug Repurposing Market Size by Type 7.2.1 Europe Drug Repurposing Market Size by Type (2016-2021) 7.2.2 Europe Drug Repurposing Market Size by Type (2022-2027) 7.2.3 Europe Drug Repurposing Market Size by Type (2016-2027) 7.3 Europe Drug Repurposing Market Size by Application 7.3.1 Europe Drug Repurposing Market Size by Application (2016-2021) 7.3.2 Europe Drug Repurposing Market Size by Application (2022-2027) 7.3.3 Europe Drug Repurposing Market Size by Application (2016-2027) 7.4 Europe Drug Repurposing Market Size by Country 7.4.1 Europe Drug Repurposing Market Size by Country (2016-2021) 7.4.2 Europe Drug Repurposing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Drug Repurposing Market Size (2016-2027) 8.2 Asia-Pacific Drug Repurposing Market Size by Type 8.2.1 Asia-Pacific Drug Repurposing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Drug Repurposing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Drug Repurposing Market Size by Type (2016-2027) 8.3 Asia-Pacific Drug Repurposing Market Size by Application 8.3.1 Asia-Pacific Drug Repurposing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Drug Repurposing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Drug Repurposing Market Size by Application (2016-2027) 8.4 Asia-Pacific Drug Repurposing Market Size by Region 8.4.1 Asia-Pacific Drug Repurposing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Drug Repurposing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Drug Repurposing Market Size (2016-2027) 9.2 Latin America Drug Repurposing Market Size by Type 9.2.1 Latin America Drug Repurposing Market Size by Type (2016-2021) 9.2.2 Latin America Drug Repurposing Market Size by Type (2022-2027) 9.2.3 Latin America Drug Repurposing Market Size by Type (2016-2027) 9.3 Latin America Drug Repurposing Market Size by Application 9.3.1 Latin America Drug Repurposing Market Size by Application (2016-2021) 9.3.2 Latin America Drug Repurposing Market Size by Application (2022-2027) 9.3.3 Latin America Drug Repurposing Market Size by Application (2016-2027) 9.4 Latin America Drug Repurposing Market Size by Country 9.4.1 Latin America Drug Repurposing Market Size by Country (2016-2021) 9.4.2 Latin America Drug Repurposing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Repurposing Market Size (2016-2027) 10.2 Middle East & Africa Drug Repurposing Market Size by Type 10.2.1 Middle East & Africa Drug Repurposing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Drug Repurposing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Drug Repurposing Market Size by Type (2016-2027) 10.3 Middle East & Africa Drug Repurposing Market Size by Application 10.3.1 Middle East & Africa Drug Repurposing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Drug Repurposing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Drug Repurposing Market Size by Application (2016-2027) 10.4 Middle East & Africa Drug Repurposing Market Size by Country 10.4.1 Middle East & Africa Drug Repurposing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Drug Repurposing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Drug Repurposing Introduction 11.1.4 Pfizer Revenue in Drug Repurposing Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Drug Repurposing Introduction 11.2.4 Roche Revenue in Drug Repurposing Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Novartis AG 11.3.1 Novartis AG Company Details 11.3.2 Novartis AG Business Overview 11.3.3 Novartis AG Drug Repurposing Introduction 11.3.4 Novartis AG Revenue in Drug Repurposing Business (2016-2021) 11.3.5 Novartis AG Recent Development 11.4 Abbott Healthcare 11.4.1 Abbott Healthcare Company Details 11.4.2 Abbott Healthcare Business Overview 11.4.3 Abbott Healthcare Drug Repurposing Introduction 11.4.4 Abbott Healthcare Revenue in Drug Repurposing Business (2016-2021) 11.4.5 Abbott Healthcare Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Drug Repurposing Introduction 11.5.4 Johnson & Johnson Revenue in Drug Repurposing Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Sandoz 11.6.1 Sandoz Company Details 11.6.2 Sandoz Business Overview 11.6.3 Sandoz Drug Repurposing Introduction 11.6.4 Sandoz Revenue in Drug Repurposing Business (2016-2021) 11.6.5 Sandoz Recent Development 11.7 Mylan Inc. 11.7.1 Mylan Inc. Company Details 11.7.2 Mylan Inc. Business Overview 11.7.3 Mylan Inc. Drug Repurposing Introduction 11.7.4 Mylan Inc. Revenue in Drug Repurposing Business (2016-2021) 11.7.5 Mylan Inc. Recent Development 11.8 Teva Pharmaceuticals 11.8.1 Teva Pharmaceuticals Company Details 11.8.2 Teva Pharmaceuticals Business Overview 11.8.3 Teva Pharmaceuticals Drug Repurposing Introduction 11.8.4 Teva Pharmaceuticals Revenue in Drug Repurposing Business (2016-2021) 11.8.5 Teva Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(生化学的薬物)の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(china drug)の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |